tiprankstipranks
Corline Biomedical AB (SE:CLBIO)
:CLBIO
Sweden Market
CLBIO
Corline Biomedical AB
RESEARCH TOOLSreports
Want to see SE:CLBIO full AI Analyst Report?

Corline Biomedical AB (CLBIO) Ratios

0 Followers

Corline Biomedical AB Ratios

SE:CLBIO's free cash flow for Q1 2026 was kr-0.57. For the 2026 fiscal year, SE:CLBIO's free cash flow was decreased by kr and operating cash flow was kr-0.57. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 6.41 4.98 2.68 3.51 5.00
Quick Ratio
 6.28 4.98 2.68 3.51 5.00
Cash Ratio
 5.14 4.27 2.25 2.51 3.64
Solvency Ratio
 -0.91 -3.04 -2.94 -0.25 0.33
Operating Cash Flow Ratio
 -2.74 -3.67 -1.10 0.13 -0.90
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr 25.50Mkr 19.16Mkr 13.20Mkr 17.01Mkr 28.80M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.15 1.05 1.09 1.07 1.08
Debt Service Coverage Ratio
 -14.02K 0.00 -720.84 -64.85 0.00
Interest Coverage Ratio
 -13.86K 0.00 -723.94 -68.77 0.00
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 0.00 <0.01 <0.01 0.00
Net Debt to EBITDA
 2.35 1.46 0.77 10.09 -10.99
Profitability Margins
Gross Profit Margin
-45.18%-185.70%137.50%113.38%96.50%
EBIT Margin
-142.61%-185.70%-236.95%-7.12%9.89%
EBITDA Margin
-141.81%-184.60%-235.98%-6.74%10.13%
Operating Profit Margin
-140.13%-185.70%-236.99%-7.14%9.89%
Pretax Profit Margin
-143.06%-192.31%-237.28%-7.23%9.89%
Net Profit Margin
-143.06%-192.31%-237.28%-7.23%9.89%
Continuous Operations Profit Margin
-143.06%-192.31%-237.28%-7.23%9.89%
Net Income Per EBT
100.00%100.00%100.00%100.00%100.00%
EBT Per EBIT
102.09%103.56%100.12%101.17%100.00%
Return on Assets (ROA)
-12.20%-14.93%-24.48%-1.81%2.29%
Return on Equity (ROE)
-16.07%-15.69%-26.69%-1.94%2.46%
Return on Capital Employed (ROCE)
-12.64%-15.15%-26.65%-1.92%2.46%
Return on Invested Capital (ROIC)
-12.64%-15.15%-26.65%-1.92%2.46%
Return on Tangible Assets
-34.06%-60.94%-109.08%-7.50%6.42%
Earnings Yield
-3.03%-3.63%-12.11%-0.56%1.18%
Efficiency Ratios
Receivables Turnover
 1.57 3.32 3.72 3.69 2.41
Payables Turnover
 12.53 23.58 -1.19 -1.70 0.19
Inventory Turnover
 17.55 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 19.85 47.23 44.63 79.71 84.11
Asset Turnover
 0.09 0.08 0.10 0.25 0.23
Working Capital Turnover Ratio
 0.37 0.47 0.65 1.09 0.73
Cash Conversion Cycle
 223.72 94.53 405.42 313.69 -1.77K
Days of Sales Outstanding
 232.06 110.01 98.17 98.94 151.70
Days of Inventory Outstanding
 20.80 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 29.14 15.48 -307.25 -214.75 1.92K
Operating Cycle
 252.86 110.01 98.17 98.94 151.70
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.68 -0.72 -0.40 0.04 -0.30
Free Cash Flow Per Share
 -0.70 -0.72 -0.74 -0.45 -0.72
CapEx Per Share
 0.02 <0.01 0.34 0.49 0.42
Free Cash Flow to Operating Cash Flow
 1.02 1.00 1.87 -10.99 2.39
Dividend Paid and CapEx Coverage Ratio
 -43.34 -376.36 -1.15 0.08 -0.72
Capital Expenditure Coverage Ratio
 -43.34 -376.36 -1.15 0.08 -0.72
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 -1.77 -2.31 -0.88 0.04 -0.27
Free Cash Flow Yield
-3.77%-4.37%-8.43%-3.04%-7.80%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -32.97 -27.57 -8.26 -177.01 85.08
Price-to-Sales (P/S) Ratio
 48.11 53.02 19.59 12.79 8.41
Price-to-Book (P/B) Ratio
 4.64 4.33 2.20 3.43 2.09
Price-to-Free Cash Flow (P/FCF) Ratio
 -26.55 -22.87 -11.87 -32.89 -12.82
Price-to-Operating Cash Flow Ratio
 -26.63 -22.93 -22.17 361.41 -30.71
Price-to-Earnings Growth (PEG) Ratio
 -0.57 0.62 >-0.01 1.00 -0.64
Price-to-Fair Value
 4.64 4.33 2.20 3.43 2.09
Enterprise Value Multiple
 -31.58 -27.26 -7.54 -179.83 72.09
Enterprise Value
 442.72M 385.08M 173.84M 303.20M 171.94M
EV to EBITDA
 -31.58 -27.26 -7.54 -179.83 72.09
EV to Sales
 44.78 50.33 17.78 12.11 7.30
EV to Free Cash Flow
 -24.72 -21.71 -10.77 -31.15 -11.13
EV to Operating Cash Flow
 -25.29 -21.77 -20.12 342.21 -26.65
Tangible Book Value Per Share
 1.01 0.78 0.62 0.81 1.35
Shareholders’ Equity Per Share
 3.92 3.79 3.98 4.34 4.40
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 0.00
Revenue Per Share
 0.39 0.31 0.45 1.16 1.10
Net Income Per Share
 -0.55 -0.59 -1.06 -0.08 0.11
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.00 1.04 1.00 1.01 1.00
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 2.76 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.24 1.20 0.37 -0.50 -2.77
Currency in SEK